MORGAN STANLEY - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2022$62,477
-68.0%
445,309
+15.0%
0.00%
Q3 2022$195,000
+56.0%
387,181
+168.5%
0.00%
Q2 2022$125,000
+26.3%
144,222
+268.7%
0.00%
Q1 2022$99,000
+7.6%
39,116
+10.1%
0.00%
Q4 2021$92,000
-41.0%
35,520
+4.3%
0.00%
Q3 2021$156,000
-48.2%
34,041
-22.1%
0.00%
Q2 2021$301,000
+119.7%
43,694
+131.9%
0.00%
Q1 2021$137,000
-19.4%
18,839
-10.6%
0.00%
Q4 2020$170,000
-13.7%
21,074
+9.3%
0.00%
Q3 2020$197,000
+838.1%
19,276
+505.0%
0.00%
Q2 2020$21,000
-4.5%
3,186
-32.9%
0.00%
Q1 2020$22,000
-86.1%
4,750
-81.7%
0.00%
Q4 2019$158,000
-40.6%
25,935
-31.6%
0.00%
Q3 2019$266,000
-51.4%
37,893
-55.0%
0.00%
Q2 2019$547,000
-37.6%
84,147
-20.3%
0.00%
Q1 2019$877,000
+89.8%
105,555
+26.6%
0.00%
Q4 2018$462,000
+100.9%
83,357
+220.2%
0.00%
Q3 2018$230,000
+820.0%
26,034
+805.8%
0.00%
Q2 2018$25,000
+177.8%
2,874
+69.1%
0.00%
Q1 2018$9,000
+200.0%
1,700
+240.0%
0.00%
Q4 2017$3,000
-89.3%
500
-80.8%
0.00%
Q3 2017$28,000
-33.3%
2,598
-46.8%
0.00%
Q2 2017$42,000
+950.0%
4,886
+1257.2%
0.00%
Q1 2017$4,000
-96.6%
360
-96.8%
0.00%
Q4 2016$116,000
+30.3%
11,162
+75.0%
0.00%
Q3 2016$89,000
+709.1%
6,380
+554.4%
0.00%
Q2 2016$11,000
-83.8%
975
-82.6%
0.00%
Q1 2016$68,000
-65.3%
5,598
-63.3%
0.00%
Q4 2015$196,000
+1860.0%
15,233
+1852.9%
0.00%
Q3 2015$10,000
-50.0%
780
-31.0%
0.00%
Q2 2015$20,000
+400.0%
1,130
+303.6%
0.00%
Q1 2015$4,000
+100.0%
280
+52.2%
0.00%
Q4 2014$2,000184
+4500.0%
0.00%
Q3 2014$040.0%0.00%
Q2 2014$04
+100.0%
0.00%
Q1 2014$020.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q1 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REDHILL BIOPHARMA LTD shareholders